| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 07/30/2009 | US20090192189 Treatment of cancers expressing p95 erbb2 |
| 07/30/2009 | US20090192109 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Kremen and/or Wnt |
| 07/30/2009 | US20090192108 Gene overexpressed in cancer |
| 07/30/2009 | US20090192107 Breast Cancer Markers |
| 07/30/2009 | US20090192088 Vascular Endothelial Growth Factor 2 |
| 07/30/2009 | US20090192086 Identification of a novel bhd gene |
| 07/30/2009 | US20090192080 Cerberus/coco derivatives and uses thereof |
| 07/30/2009 | US20090191650 Diagnosing alzheimer's disease via presence of variant brain membrane protein |
| 07/30/2009 | US20090191645 Compounds and methods for modulating integrin activity |
| 07/30/2009 | US20090191640 Methods of Screening for Atherosclerosis |
| 07/30/2009 | US20090191629 Mammalian chemokine reagents |
| 07/30/2009 | US20090191592 Glycoengineered, recombinant antibody |
| 07/30/2009 | US20090191579 Analgesia with minimal tolerance and dependence by a mu opioid receptor agonist that also binds filamin a |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |
| 07/30/2009 | US20090191569 Mammalian Cytokines; Related Reagents |
| 07/30/2009 | US20090191550 Diagnosis of whipple's disease |
| 07/30/2009 | US20090191536 Rabbit monoclonal antibodies to hepatitis B surface antigens and methods of using the same |
| 07/30/2009 | US20090191268 Allergy vaccines |
| 07/30/2009 | US20090191241 Method and compositions for immunization with the pseudomonas v antigen |
| 07/30/2009 | US20090191234 Vaccine |
| 07/30/2009 | US20090191231 Prevention and treatment of amyloidogenic disease |
| 07/30/2009 | US20090191222 Metastatic human tumor associated molecule, methods to detect both activated gene and protein and to interfere with gene expression |
| 07/30/2009 | US20090191221 Antibodies recognizing a carbohydrate containing epitope on cd-43 and cea expressed on cancer cells and methods using same |
| 07/30/2009 | US20090191219 Methods for diagnosing and treating obesity by modulating the activity of auto-antibodies against the melanocortin-4 receptor |
| 07/30/2009 | US20090191216 Antibody or a fragment thereof, having neutralizing activity against HIV |
| 07/30/2009 | US20090191215 Treatment with anti-VEGF Antibodies |
| 07/30/2009 | US20090191214 Anti-human il-21 monoclonal antibodies |
| 07/30/2009 | US20090191213 Compositions and methods for regulating NK cell activity |
| 07/30/2009 | US20090191212 Heavy chain fragments, light chain fragments, and CDRs of fully human antibodies, that bind to angiopoietin-2; inhibits undesired angiogenesis |
| 07/30/2009 | US20090191211 METHODS FOR DAMAGING CELLS USING EFFECTOR FUNCTIONS OF ANTI-EphA4 ANTIBODIES |
| 07/30/2009 | US20090191209 Methods and compositions for targeting polyubiquitin |
| 07/30/2009 | US20090191208 Antibodies against flagellin and uses thereof |
| 07/30/2009 | US20090191206 Human Semen Enhancer of Viral Infection Peptides (SEVI) and Their Use |
| 07/30/2009 | US20090191205 Compositions and Methods for Treating and Diagnosing Cancer |
| 07/30/2009 | US20090191204 Anti-psgl-1 antibodies |
| 07/30/2009 | US20090191200 Method for the Treatment of Multiple Sclerosis by Inhibiting IL-17 Activity |
| 07/30/2009 | US20090191199 Glycoengineered, recombinant antibody |
| 07/30/2009 | US20090191197 Cancerous disease modifying antibodies |
| 07/30/2009 | US20090191193 Aryl Vinyl Sulfides, Sulfones, Sulfoxides and Sulfonamides, Derivatives Thereof and Therapeutic Uses Thereof |
| 07/30/2009 | US20090191192 Humanized anti-ccr2 antibodies and methods of use therefor |
| 07/30/2009 | US20090191191 Methods for the Modulation of IL-13 |
| 07/30/2009 | US20090191190 Anti-ABeta Globulomer Antibodies, Antigen-Binding Moieties Thereof, Corresponding Hybridomas, Nucleic Acids, Vectors, Host Cells, Methods of Producing Said Antibodies, Compositions Comprising Said Antibodies, Uses Of Said Antibodies And Methods Of Using Said Antibodies |
| 07/30/2009 | US20090191189 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 07/30/2009 | US20090191187 Antibodies against interleukin-1 receptor and uses thereof |
| 07/30/2009 | US20090191186 Antibodies to the PcrV Antigen of Pseudomonas aeruginosa |
| 07/30/2009 | US20090191130 De novo synthesis of bacteriochlorins |
| 07/30/2009 | US20090191120 Cancerous disease modifying antibodies |
| 07/30/2009 | US20090191119 Cancerous disease modifying antibodies |
| 07/30/2009 | US20090191118 Cytotoxicity mediation of cells evidencing surface expression of TROP-2 |
| 07/30/2009 | US20090191117 Anti-Integrin Antibodies, Compositions, Methods and Uses |
| 07/30/2009 | CA2713055A1 Selective exosite inhibition of papp-a activity against igfbp-4 |
| 07/30/2009 | CA2712989A1 Optimized cd40 antibodies and methods of using the same |
| 07/30/2009 | CA2712697A1 Ron antibodies and uses thereof |
| 07/30/2009 | CA2712221A1 Humanized antibodies specific for von willebrand factor |
| 07/30/2009 | CA2712220A1 Humanized anti-human nkg2a monoclonal antibody |
| 07/30/2009 | CA2712182A1 Proteinaceous binding molecules comprising purification tags or inert variable domains |
| 07/30/2009 | CA2711826A1 Ferroportin antibodies and methods of use |
| 07/29/2009 | EP2083089A1 Detection of mutations in a gene associated with resistance to viral infection, oas1 |
| 07/29/2009 | EP2083079A1 Apo-2DcR |
| 07/29/2009 | EP2083018A2 Compositions and methods relating to STOP-1 |
| 07/29/2009 | EP2083017A1 Antibody having enhanced adcc activity and method for production thereof |
| 07/29/2009 | EP2083016A1 Bacterial superantigen vaccines |
| 07/29/2009 | EP2082749A2 Prevention and treatment of Alzheimer's disease |
| 07/29/2009 | EP2082032A1 Hybridomas producing antibodies against non functional p2x7 receptor |
| 07/29/2009 | EP2081963A2 Methods for reducing phosphate absorption |
| 07/29/2009 | EP2081962A2 Novel anti-notch3 antibodies and their use in the detection and diagnosis of disease |
| 07/29/2009 | EP2081961A2 Therapeutic uses of tim-3 modulators |
| 07/29/2009 | EP2081960A1 Intranasal delivery of polypeptides and proteins |
| 07/29/2009 | EP2081595A2 Combination treatment of cd38-expressing tumors |
| 07/29/2009 | EP2081592A1 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses |
| 07/29/2009 | EP2081442A2 Compositions, methods and kits for isolating nucleic acids from body fluids using anion exchange media |
| 07/29/2009 | EP1670511B1 Cripto antagonism of activin and tgf-b signaling |
| 07/29/2009 | EP1558277A4 Treatment of inflammatory bowel disease |
| 07/29/2009 | EP1491890B1 Method of evaluating hair growth-promoting activity |
| 07/29/2009 | EP1293567B1 Ligand to gpr8 and dna thereof |
| 07/29/2009 | EP1292676B1 Mutation associated with epilepsy |
| 07/29/2009 | EP1283868B1 Isolated gum operon from xyllela fastidiosa, isolated nucleic acid molecules therefrom, and uses thereof |
| 07/29/2009 | EP1189641B1 HUMANIZED ANTI-ErbB2 ANTIBODIES AND TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 07/29/2009 | EP1086223B1 Novel serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 07/29/2009 | EP1073463B1 Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation |
| 07/29/2009 | CN101495515A High affinity human and humanized anti-alpha5beta1 integrin function blocking antibodies with reduced immunogenicity |
| 07/29/2009 | CN101495514A Glyco-engineered antibodies |
| 07/29/2009 | CN101495513A Angiopoietin-2 specific binding agents |
| 07/29/2009 | CN101495512A A diabody which specifically binds streptococcus surface antigen I/II and methods of use thereof |
| 07/29/2009 | CN101495511A Neutralizing antibodies to influenza viruses |
| 07/29/2009 | CN101495510A Single chain FC polypeptides |
| 07/29/2009 | CN101495509A Sp35 antibodies and uses thereof |
| 07/29/2009 | CN101492507A Complex of Fab fragment of C2H7 and CD20 antigen epitope polypeptide |
| 07/29/2009 | CN101492506A CIAPIN1 monoclone antibody for multidrug resistant differential diagnosis of stomach cancer and method for preparing the same |
| 07/29/2009 | CN101492505A Specific combined polypeptide for lung cancer, preparation and uses thereof |
| 07/29/2009 | CN101492504A Preparation of monoclone antibody of anti-HnRNPB1 antigen and uses thereof |
| 07/29/2009 | CN101492503A Protein, method for immobilizing protein, structure, biosensor, nucleic acid, vector and kit for detecting target substance |
| 07/29/2009 | CN101492496A A method for identification, isolation and production of antigens to a specific pathogen |
| 07/29/2009 | CN100520408C Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors |
| 07/29/2009 | CN100519749C Agonist anti-TRK-C monoclonal antibodies |
| 07/29/2009 | CN100519735C Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 07/29/2009 | CN100519584C Antibodies against fibroblast growth factor 23 |
| 07/29/2009 | CN100519583C SARS neutralization antibody and application |
| 07/29/2009 | CN100519578C White candidas transcription factor gene and its use |
| 07/29/2009 | CN100519513C Chloramineone and haptene, immuongen, antibody and coupler of its metabolite |